Hepalink USA
Hepalink USA, a subsidiary of Hepalink Pharmaceutical Co., Ltd., is a leading player in the biopharmaceutical industry, specialising in the development and production of heparin and its derivatives. Headquartered in China, the company has established a significant operational presence in the United States, focusing on the production of high-quality anticoagulants and related products. Founded in 1998, Hepalink has achieved notable milestones, including becoming one of the largest heparin manufacturers globally. The company’s core offerings include heparin sodium, low molecular weight heparins, and other innovative anticoagulant therapies, distinguished by their rigorous quality standards and advanced manufacturing processes. Hepalink USA is recognised for its commitment to research and development, positioning itself as a trusted partner in the healthcare sector, with a strong emphasis on safety and efficacy in its product line.
DitchCarbon Score
How does Hepalink USA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hepalink USA's score of 20 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hepalink USA's reported carbon emissions
Hepalink USA, headquartered in China (CN), currently does not have publicly available data regarding its carbon emissions or specific climate commitments. As such, there are no reported figures for emissions in kg CO2e, nor are there defined reduction targets or initiatives outlined in their sustainability strategy. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical and biotechnology sectors are increasingly focusing on reducing their carbon footprints and committing to sustainability practices. This often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising environmental impact. Hepalink USA may be participating in similar industry trends, but without concrete data or commitments, it is difficult to provide a detailed overview of their climate actions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hepalink USA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
